GSK:LON
GSK plc
1.772,00 GBX
arrow_upward
+0,37%(+6,50) 1D
7. okt., 10:35:37 GMT +1 · GBX
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za GSK …
Odpri
1.754,50 GBX
Visoka
1.773,50 GBX
Nizka
1.746,50 GBX
Tržna kapitalizacija
72,52 mrd.
Povprečni promet
5,45 mio.
Promet
599,64 tis.
Dividenda
3,84 %
Četrtletna dividenda
17,00 GBX
Prvi trgovalni dan brez upravičenja do dividende
13. avg. 2026
Razmerje med ceno delnice in čistim dobičkom
15,02
52-tedenski najvišji tečaj
2.282,00 GBX
52-tedenski najnižji tečaj
1.592,00 GBX
Čisti dobiček na delnico
1,18 GBX
Št. izdanih delnic
4,32 mrd.
Št. zaposlenih
67 tis.
Odpri
1.754,50 GBX
Visoka
1.773,50 GBX
Nizka
1.746,50 GBX
Tržna kapitalizacija
72,52 mrd.
Povprečni promet
5,45 mio.
Promet
599,64 tis.
Dividenda
3,84 %
Četrtletna dividenda
17,00 GBX
Prvi trgovalni dan brez upravičenja do dividende
13. avg. 2026
Razmerje med ceno delnice in čistim dobičkom
15,02
52-tedenski najvišji tečaj
2.282,00 GBX
52-tedenski najnižji tečaj
1.592,00 GBX
Čisti dobiček na delnico
1,18 GBX
Št. izdanih delnic
4,32 mrd.
Št. zaposlenih
67 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
AD HOC NEWS
·
pred 1 uro
Berenberg keeps Buy rating and GBp 2,200 target for GSK stock
AD HOC NEWS
·
pred 7 urami
GSK Pharma stock heads toward Q2 results after trading window closes
Stock Titan
·
pred 18 urami
19,352 GSK (GSK) shares join London trading under its Share Save Plan 2022.
London South East
·
pred 19 urami
GSK celebrates "important insights" from Cabenuva study
Profil
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
Vizitka: GSK plc
Generalni direktorEmma Walmsley | Emma Walmsley
Št. zaposlenih66,8 tis.
Ustanovljeno27. dec. 2000
Sedež-
Sektor-
Spletno mestogsk.com